A Study of Coverage and Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Rewa District Of Madhya Pradesh

Authors

  • Amarnath Gupta Bundelkhand Medical College, Sagar, Madhya Pradesh
  • Pankaj Prasad Bundelkhand Medical College, Sagar, Madhya Pradesh
  • Sukhendra P Singh Bundelkhand Medical College, Sagar, Madhya Pradesh

Keywords:

Coverage, Compliance, Mass Drug Administration, Filariasis

Abstract

Introduction: Lymphatic filariasis (LF), commonly known as elephantiasis is a global problem affecting more than 120 million people in 80 countries. It is one of the leading causes of long term permanent disability, accounting for more than 5 million disability adjusted life years (DALYs) annually. Present study was carried out to evaluate the coverage, compliance and reasons for non compliance of MDA in Rewa district of MP.

Materials & methods: A Community based cross-sectional Study was conducted for evaluation of coverage and compliance of MDA by Household survey in four selected clusters (three rural and one urban) of Rewa District of Madhya Pradesh as per NVBDCP guidelines. Predesigned questionnaire was used to collect information from 120 families. Household survey was conducted within three weeks of MDA Campaign

Results: Out of 667 persons only 618 (92.65%) persons were found eligible for MDA. Coverage rate was 80.42% &Compliance rate was 67.96%. Compliance rate was higher among females 73.84% as compared to males 62.34%. The main reason for non compliance was (42.42%) persons were not at home and (37.37%) forget to take the tablets. Only (74.16%) respondents had some knowledge about DEC, (69.16%) knew about lymphatic filariasis and only (27.5%) had knowledge about disease transmission.

Conclusion: Improving the coverage and compliance rate of DEC consumption is the most important factor for the success of MDA. This can be done by better social mobilization and monitoring. There should be more involvement of the community leaders, educational institutions, volunteers and NGOs and private practitioners. 

References

Suryakantha A H. Community Medicine with Recent Advances, 2nd ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd. 2010 P407.

World Health Organization. First WHO Report on Neglected Tropical Diseases 2010: Working to Overcome the Global Impact of Neglected Tropical Diseases. ISBN 97892 4 1564090. Available from www.who.int/neglected_diseases/2010report/en/‎. Accessed on 24 Oct. 2013.

Filariasis Control in India and its Elimination. Available from http://stg2.kar.nic.in/healthnew/pdf/copy of ELFG2015.04_REVISED2_18.8.pdf. Accessed on 18 Oct. 2013.

National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Lymphatic Filariasis. Magnitude of Disease. Available from: http://nvbdcp.gov.in/fil10.html. Accessed on 16 Oct.2013.

ChandrakantLahariya& Ashok Mishra, “Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study” J Vector Borne Disease 45, December 2008, P313–20.

National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Filaria Endemic Districts. Available from http://www.nvbdcp.gov.in/fil-map.html. Accessed on 16 Oct.2013.

SuryakanthaA H. Community Medicine with Recent Advances, 2nd ed. New Delhi: Jaypee Brothers Medical Publishers (P) Ltd. 2010 P 412.

National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Guidelines on Elimination of Lymphatic Filariasis India. Available from Http://Nvbdcp.Gov.In/Doc/GuidelinesFilariasis-Elimination-India.pdf. Accessed on 22 Oct.2013.

NirgudeAbhay S, NaikPoonam R, KondaguntaNagaraj , ReshmiSidramappa S, TakalkarAnant A, Prasad VG. Evaluation of coverage and compliance of Mass drug administration programme 2011 for elimination of lymphatic filariasis in Nalgonda district of Andhra Pradesh, India. National Journal of Community Medicine Vol 3 issue 2 P 288-93.

GodaleLata B, UkarandeBalaji V. a study on coverage evaluation, complianceand awareness of mass drug administration for elimination of lymphatic filariasis in Osmanabad District. National Journal of Community Medicine. Vol.3 issue 3 P 391-94.

Mehta Shreyash, Shah Vinesh, VermaAnupam Patel NB, Bansal RK.Comparison of coverage and compliance of mass drug administration 2012 in Surat, India. National Journal of Community Medicine Vol 3 issue 3 P 468-72.

National Vector Borne Disease Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India. Guidelines on Filariasis Control in India and it’s Elimination (2009).Available fromhttp://www.nvbdcp.gov.in/Doc/Guidelines-Filariasis-Elimination-India.pdf. Accessed on 14 Oct.2013.

Karamkar P Ray, K Mitra, ChatterjeeAnirban, Jana P K, Bhattacharya S, Lahiri SK. A study on coverage,compliance and awareness about Mass Drug Administration for elimination of lymphatic filariasis in a district of West Bengal, India. J Vector Borne Dis 2011;48: P101-4.

Downloads

Published

2014-03-31

How to Cite

1.
Gupta A, Prasad P, Singh SP. A Study of Coverage and Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Rewa District Of Madhya Pradesh. Natl J Community Med [Internet]. 2014 Mar. 31 [cited 2024 Apr. 26];5(01):38-41. Available from: https://njcmindia.com/index.php/file/article/view/1311

Issue

Section

Original Research Articles